A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1999
12/17/1999	CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999	WO1999064596A2 Proteins regulating gene expression
12/16/1999	WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999	WO1999064593A2 Cell cycle regulation proteins
12/16/1999	WO1999064584A2 Protein for regulating apoptosis
12/16/1999	WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999	WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999	WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999	WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999	WO1999064420A1 β-CARBOLINE COMPOUNDS
12/16/1999	WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	WO1999064405A1 Crystalline efavirenz
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064400A1 INHIBITORS OF p38
12/16/1999	WO1999064074A1 Methods and compositions for delivering proteins to macrophage cells and cells of macrophage derived lineage
12/16/1999	WO1999064071A1 A method for preparing a carbonized resin dna immunoadsorbent
12/16/1999	WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999	WO1999064066A1 Immune tolerance-inducing agents containing hard keratin or keratin-like substance
12/16/1999	WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999	WO1999064022A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
12/16/1999	WO1999064021A1 hCEPR RECEPTOR
12/16/1999	WO1999064011A1 Drugs
12/16/1999	WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999	WO1999063975A2 A method for stimulating the immune system
12/16/1999	WO1999041375A3 Human receptor proteins
12/16/1999	WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999	WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999	CA2335339A1 .beta.-carboline compounds
12/16/1999	CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999	CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999	CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999	CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999	CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999	CA2333550A1 Crystalline efavirenz
12/16/1999	CA2330168A1 Protein for regulating apoptosis
12/16/1999	CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same
12/16/1999	CA2329688A1 Cell cycle regulation proteins
12/16/1999	CA2329685A1 Proteins regulating gene expression
12/15/1999	EP0963755A2 Use of benzopyranes for preventing allograft rejection
12/15/1999	EP0963440A1 Improved methods for transducing cells
12/15/1999	EP0963377A1 Interleukin-19
12/15/1999	EP0963371A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation
12/15/1999	EP0765305B1 Anti-inflammatory compounds
12/15/1999	EP0749434B1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/15/1999	EP0658110B1 Use of norastemizole for the treatment of allergic rhinitis
12/15/1999	CN1238782A Colostrinin and uses thereof
12/15/1999	CN1238781A Heptapeptide oxytocin analofues
12/15/1999	CN1238216A Oral immunity enhancing agent
12/15/1999	CN1238207A Tonic liquid of black ewe's placenta extract and its preparing method
12/14/1999	US6001998 Macrocyclic lactone compounds and their production process
12/14/1999	US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999	US6001973 Antagonists of interleukin-15
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001885 Retinoid inhibition of expression of VEGF
12/14/1999	US6001839 Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001799 Method of treating hepatitis C in non-responders to interferon treatment
12/14/1999	US6001651 Antisense modulation of LFA-3
12/14/1999	US6001649 Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999	US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999	US6001369 Recombinant fowlpox virus comprising a foreign dna inserted into the fowlpox virus genomic dna, wherein the foreign dna sequence is inserted within a fragment of the fowlpox virus genomic dna and is capable of being expressed in host cell
12/14/1999	US6001365 Conjugating empty human class i molecules surface-expressed on drosophila cells to a toxin in vitro; contacting said molecules with antigenic peptides derived from said transplanted tissue to load said conjugates with peptides
12/14/1999	US6001364 Comprising a baseplate structure having a plurality of oxime bonds, wherein each oxime bond links a specifically active molecule to the baseplate; for inducing an immune response in an animal
12/14/1999	US6001358 Useful for treatment of autoimmune diseases
12/14/1999	US6001356 Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
12/14/1999	CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2092720C Macrophage activating factor from vitamin d binding protein
12/14/1999	CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999	CA2010636C Substituted pyrroles
12/09/1999	WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999	WO1999062923A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
12/09/1999	WO1999062914A1 Cyclic boroproline compounds
12/09/1999	WO1999062897A1 Hiv integrase inhibitors
12/09/1999	WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999	WO1999062550A1 Pan-specific anti-allergy therapy
12/09/1999	WO1999062546A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/09/1999	WO1999062541A1 Immunosuppressants containing clusterins
12/09/1999	WO1999062540A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062527A1 nrdE
12/09/1999	WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999	WO1999062516A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
12/09/1999	WO1999051275A3 Mesenchymal stem cells as immunosuppressants
12/09/1999	WO1999051266A3 Derivatives of pneumococcal choline binding proteins for vaccines
12/09/1999	WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999	WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999	WO1999038528A3 Vaccine formulations
12/09/1999	WO1999024066A3 Methods and compositions for enhancing immune response and for the production of in vitro mabs
12/09/1999	DE19825621A1 Protein zur Regulation von Apoptose Protein for regulation of apoptosis
12/09/1999	CA2333771A1 Hiv integrase inhibitors
12/09/1999	CA2333315A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	CA2330225A1 Immunostimulatory oligonucleotides with modified bases and methods of use thereof

1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 1172